NCT01012726 Study About the Effect of Doxycycline and Acetylcystein in the Treatment of CD-associated Fistulae Status TERMINATED Phase NA
NCT01012570 The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients Status TERMINATED Phase N/A
NCT01009281 An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease Status TERMINATED Phase PHASE2
NCT00989573 A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00988832 An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066) Status COMPLETED Phase N/A
NCT00972218 Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease Status WITHDRAWN Phase PHASE4
NCT00968721 Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use Status TERMINATED Phase N/A
NCT00946946 Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine Status COMPLETED Phase PHASE3
NCT00944736 Effect of VSL#3 on Intestinal Permeability in Pediatric Crohn's Disease Status COMPLETED Phase PHASE3
NCT00936585 NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease Status TERMINATED Phase NA
NCT00917514 An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen Status COMPLETED Phase N/A
NCT00899678 The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents Status TERMINATED Phase PHASE2
NCT00851565 Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy Status UNKNOWN Phase PHASE4
NCT00838149 Effect of Glutamine on Intestinal Permeability in Crohn's Disease Status COMPLETED Phase PHASE1